Imaging in Stem Cell Transplant and Cell-based Therapy

(Nancy Kaufman) #1

68



  1. Ma XR, Tang YL, Xuan M, Chang Z, Wang XY, Liang XH.  Transplantation of autologous
    mesenchymal stem cells for end-stage liver cirrhosis: a meta-analysis based on seven con-
    trolled trials. Gastroenterol Res Pract. 2015;2015:908275.

  2. Gomez-Gomez GJ, Flores AI. Therapy with stem cells in inflammatory bowel disease. World
    J Gastroenterol. 2014;20(5):1211–27.

  3. Flores AI, Gómez-Gómez GJ, Masedo-González Á, Martínez-Montiel MP. Stem cell therapy
    in inflammatory bowel disease: a promising therapeutic strategy? World J  Stem Cells.
    2015;7(2):343.

  4. Ciccocioppo R, Bernardo ME, Sgarella A, Maccario R, Avanzini MA, Ubezio C, Minelli A,
    Alvisi C, Vanoli A, Calliada F, Dionigi P, Perotti C, Locatelli F, Corazza GR. Autologous bone
    marrow-derived mesenchymal stromal cells in the treatment of fistulising Crohn’s disease.
    Gut. 2011;60(6):788–98.

  5. Lee WY, Park KJ, Cho YB, Yoon SN, Song KH, Kim DS, Jung SH, Kim M, Yoo HW, Kim I,
    Ha H, Yu CS. Autologous adipose tissue-derived stem cells treatment demonstrated favorable
    and sustainable therapeutic effect for Crohn’s fistula. Stem Cells. 2013;31(11):2575–81.

  6. Weiss DJ, Casaburi R, Flannery R, LeRoux-Williams M, Tashkin DP. A placebo-controlled,
    randomized trial of mesenchymal stem cells in COPD. Chest J. 2013;143(6):1590–8.

  7. Stessuk T, Ruiz MA, Greco OT, Bilaqui A, Ribeiro-Paes MJDO, Ribeiro-Paes JT. Phase I clini-
    cal trial of cell therapy in patients with advanced chronic obstructive pulmonary disease: fol-
    low- up of up to 3 years. Rev Bras Hematol Hemoter. 2013;35(5):352–7.

  8. Tzouvelekis A, Paspaliaris V, Koliakos G, Ntolios P, Bouros E, Oikonomou A, Zissimopoulos
    A, Boussios N, Dardzinski B, Gritzalis D, Antoniadis A, Froudarakis M, Kolios G, Bouros
    D. A prospective, non-randomized, no placebo-controlled, phase Ib clinical trial to study the
    safety of the adipose derived stromal cells-stromal vascular fraction in idiopathic pulmonary
    fibrosis. J Transl Med. 2013;11(171):10–1186.

  9. Luan Y, Zhang X, Qi TG, Cheng GH, Sun C, Kong F.  Long-term research of stem cells in
    monocrotaline-induced pulmonary arterial hypertension. Clin Exp Med. 2014;14(4):439–46.

  10. Chen SL, Fang WW, Ye F, Liu YH, Qian J, Shan SJ, Zhang JJ, Chunhua RZ, Liao LM, Lin S,
    Sun JP. Effect on left ventricular function of intracoronary transplantation of autologous bone
    marrow mesenchymal stem cell in patients with acute myocardial infarction. Am J  Cardiol.
    2004;94(1):92–5.

  11. Hare JM, Traverse JH, Henry TD, Dib N, Strumpf RK, Schulman SP, Hermiller JB. A random-
    ized, double-blind, placebo-controlled, dose-escalation study of intravenous adult human mes-
    enchymal stem cells (prochymal) after acute myocardial infarction. J  Am Coll Cardiol.
    2009;54(24):2277–86.

  12. Neeman Z, Hirshberg B, Harlan D, Wood BJ. Radiologic aspects of islet cell transplantation.
    Curr Diab Rep. 2006;6(4):310–5.

  13. Ezquer M, Arango-Rodriguez M, Giraud-Billoud M, Ezquer F. Mesenchymal stem cell ther-
    apy in type 1 diabetes mellitus and its main complications: from experimental findings to clini-
    cal practice. J Stem Cell Res Ther. 2014;4:227.

  14. Hu J, Yu X, Wang Z, Wang F, Wang L, Gao H, Chen Y, Zhao W, Jia Z, Yan S, Wang Y. Long
    term effects of the implantation of Wharton’s jelly-derived mesenchymal stem cells from the
    umbilical cord for newly-onset type 1 diabetes mellitus. Endocr J. 2013;60(3):347–57.

  15. Hare JM, Fishman JE, Gerstenblith G, Velazquez DLD, Zambrano JP, Suncion VY, Tracy M,
    Ghersin E, Johnston PV, Brinker JA, Breton E, Davis-Sproul J, Schulman IH, Byrnes J,
    Mendizabal AM, Lowery MH, Rouy D, Altman P, Wong Po Foo C, Ruiz P, Amador A, Da
    Silva J, McNiece IK, Heldman AW, George R, Lardo A. Comparison of allogeneic vs autolo-
    gous bone marrow–derived mesenchymal stem cells delivered by transendocardial injection in
    patients with ischemic cardiomyopathy: the POSEIDON randomized trial. JAMA. 2012;
    308(22):2369–79.

  16. Sun L, Wang D, Liang J, Zhang H, Feng X, Wang H, Hua B, Liu B, Ye S, Hu X, Xu W, Zeng
    X, Hou Y, Gilkeson GS, Silver RM, Lu L, Shi S.  Umbilical cord mesenchymal stem cell
    transplantation in severe and refractory systemic lupus erythematosus. Arthritis Rheum.
    2010;62(8):2467–75.


R. Ram et al.
Free download pdf